Quantcast

Rockwell Nutrition Promotes Prostabel

August 30, 2012

Rockwell Nutrition promotes Prostabel, a natural health supplement that helps maintain healthy prostate function.

Wilmington, NC (PRWEB) August 29, 2012

Rockwell Nutrition advocates the use of Prostabel, a dietary supplement that is a combination of Pao Pereira and Rauwolfia Vomitoria extracts, for preventing serious prostate problems in men.

Each capsule of Prostabel contains 35% Pao Pereira and 30% Rauwolfia extract. Rockwell Nutrition decided to promote Prostabel, saying that “Now more than ever, it is important for men over-the-age-of-55 to start thinking about maintaining and/or improving the state of their prostate health.”

Rockwell Nutrition narrates how Pao Pereira helps and reinforces the immune system, effectively neutralizing undesirable cells in the process while Rauwolfia Vomitoria protects cells and combats aggressive and toxic substances, thus improving cellular regulation.

“One out of every six American men face the risk of developing serious prostate problems during his lifetime,” according to Rockwell Nutrition.

The website also warned that hormone or corticosteroid treatments may affect the efficacy of the supplement, thus their combination is not recommended.

The report continues by saying that an individual can take up to 10 capsules of the vegetarian supplement per day and that the dosage depends on the recommendation of a health care practitioner.

###

Rockwell Nutrition is dedicated to providing access to and information about the highest-quality supplements in the industry. We review thousands of products every year and offer only the cream of the crop. Unfortunately, there are many companies out there who manufacture products that contain nutrients that are biochemically unavailable or are filled with toxins and allergens. Rockwell helps you separate bogus supplements from those that are scientifically and clinically proven to work, and provides recommendation on only the best of the best.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/8/prweb9843713.htm


Source: prweb



comments powered by Disqus